Skip to main content
Fanli Digital Technology Co., Ltd logo

Fanli Digital Technology Co., Ltd — Investor Relations & Filings

Ticker · 600228 ISIN · CNE000000Y78 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 2,251 across all filing types
Latest filing 2017-05-05 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 600228

About Fanli Digital Technology Co., Ltd

https://corp.fanli.com/

Fanli Digital Technology Co., Ltd. provides e-commerce integration and digital marketing services. The company operates a comprehensive platform that connects consumers with various online retail ecosystems through value-added services such as cash-back rewards, discount coupons, and promotional insights. Its core business model focuses on performance-based marketing, utilizing data-driven strategies to facilitate sales conversions for brand partners. Key offerings include brand promotion, user loyalty management, and targeted advertising solutions. By integrating diverse shopping channels into a single interface, the company optimizes the consumer purchasing journey and provides brands with scalable traffic acquisition tools. The platform serves as a strategic intermediary, leveraging user behavioral data to enhance marketing efficiency and provide measurable returns for merchants while delivering cost savings to a broad user base.

Recent filings

Filing Released Lang Actions
关于信息披露义务人对《详式权益变动报告书》的更正公告
Major Shareholding Notification Classification · 95% confidence The document is a correction announcement regarding a previously disclosed detailed equity change report (详式权益变动报告书) by Jiangxi Changjiu Biochemical Co., Ltd. It details corrections to the original equity change report, including clarifications on shareholder structure, funding sources, and future plans related to shareholding and business adjustments. The document is an announcement correcting and clarifying information about an equity change report rather than the report itself. It does not contain financial statements or substantive financial data but focuses on disclosure obligations and regulatory compliance related to equity changes. Therefore, it fits best under the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels and related disclosures.
2017-05-05 Chinese
公司股票复牌的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Jiangxi Changjiu Biochemical Co., Ltd. regarding the resumption of trading of its stock. It details the transfer of controlling shareholder equity, inquiries from the Shanghai Stock Exchange, and responses to those inquiries. The document is relatively short (1583 characters) and primarily serves as a formal notice about the stock resumption and related equity transfer events. It does not contain financial statements, detailed financial performance data, or comprehensive report content. It is an official announcement about a stock trading status change rather than a full report or detailed financial disclosure. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2017-04-28 Chinese
北京市中伦律师事务所关于上海证券交易所《关于对江西昌九生物化工股份有限公司权益变动信息披露相关事项的问询函（二）》相关法律问题的专项核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion from a law firm addressing inquiries from the Shanghai Stock Exchange regarding equity change disclosures related to a specific transaction involving Jiangxi Changjiu Biochemical Co., Ltd. It discusses legal issues, litigation, arbitration, internal decision-making procedures, and compliance with regulatory requirements for a share acquisition. The document is a specialized legal review and verification report rather than a financial report, earnings release, or management discussion. It does not contain financial statements or earnings data but focuses on legal and regulatory compliance matters related to equity changes and share transfer. This fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2017-04-28 Chinese
长江证券承销保荐有限公司关于上海证券交易所《关于对江西昌九生物化工股份有限公司权益变动信息披露相关事项的问询函（二）》相关问题的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed special investigation opinion issued by Changjiang Securities Underwriting and Sponsorship Co., Ltd. in response to an inquiry letter from the Shanghai Stock Exchange regarding equity change information disclosure related to Jiangxi Changjiu Biochemical Co., Ltd. The content includes legal references, detailed descriptions of lawsuits, arbitration cases, internal decision-making procedures, compliance with acquisition regulations, and financial advisor opinions on the legitimacy and impact of these matters. It is a formal audit and verification report by a financial advisor on specific regulatory inquiries, focusing on legal and compliance issues rather than general financial performance or earnings. The document is not an annual or interim report, earnings release, or a simple announcement. It is a standalone audit-related report addressing regulatory inquiries and compliance verification. Therefore, it fits the category of Audit Report / Information (AR). The document length (7572 characters) and detailed content support this classification with high confidence. FY 2016
2017-04-28 Chinese
上海市方达律师事务所关于上海证券交易所《关于对江西昌九生物化工股份有限公司权益变动信息披露相关事项的问询函（二）》之专项核查法律意见
Regulatory Filings Classification · 95% confidence The document is a legal opinion issued by a law firm (Shanghai Fangda Law Firm) regarding an inquiry letter from the Shanghai Stock Exchange about equity change disclosures related to Jiangxi Changjiu Biochemical Co., Ltd. It discusses the legal verification of the qualifications and compliance of the acquiring party in a 100% equity transfer transaction. The document references regulatory rules such as the Securities Law, the Shanghai Stock Exchange inquiry letter, and acquisition management measures. It is a specialized legal opinion related to a transaction and regulatory inquiry, not a financial report, earnings release, or management discussion. It is not a report publication announcement or a certification letter but a detailed legal opinion on a specific regulatory inquiry. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements, compliance documents, and miscellaneous filings that do not fit other categories.
2017-04-28 Chinese
招商证券股份有限公司关于上海证券交易所《关于对江西昌九生化股份有限公司权益变动信息披露相关事项的问询函（二）》之核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from a financial advisor regarding a shareholding change and acquisition inquiry by the Shanghai Stock Exchange. It discusses the qualifications, integrity, and intentions of the acquirer in relation to a specific equity transfer. The content focuses on compliance with acquisition regulations, shareholder status, and legal adherence, without presenting financial statements or earnings data. It is not an annual or interim report, earnings release, or management discussion. It is also not a simple announcement or certification but a detailed advisory opinion related to a shareholding change and acquisition process. This fits best under Regulatory Filings (RNS) as it is a regulatory compliance and disclosure document that does not fit other specific categories like M&A filings or capital updates.
2017-04-28 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.